Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US ...

Shares of pharmaceutical companies declined after U.S. President Donald Trump announced plans to lower U.S. prescription drug ...

China’s exports surged as shipments to Southeast Asian countries soared, offsetting a sharp drop in outbound goods to the U.S ...

Kroger, Albertsons and others allege an unlawful monopoly in one legal case and aim to recover overcharges for a drug in ...

Takeda will host an investor call on Sunday ... but it is to illustrate that as a global innovative pharmaceutical company, we have a very strong presence in the U.S., which is, by far today ...

As such, the Zacks rating upgrade for Takeda Pharmaceutical Co. is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price. The change in a company ...

Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Takeda Pharmaceutical Co. imply an improvement in the company's underlying business. Investors should show ...

Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US ...

Takeda will be investing approximately $30 billion into its U.S. operations over the next five years, the company announced.

Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US ...